United Therapeutics reported $4.32B in Equity Capital and Reserves for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Amarin AMRN:US $ 580.04M 61.07M
Ardelyx ARDX:US $ 53.04M 11.15M
Baxter International BAX:US $ 8859M 216M
Bayer BAYN:GR € 38019M 582M
Biocryst Pharmaceuticals BCRX:US $ -213.23M 49.02M
Biogen BIIB:US $ 11872.5M 630.2M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Emergent Biosolutions EBS:US $ 1513.2M 62.1M
Esperion Therapeutics ESPR:US $ -291698000 42.66M
Gilead Sciences GILD:US $ 20215M 288M
GlaxoSmithKline GSK:LN 1637400M 19300M
Halozyme Therapeutics HALO:US $ 293.17M 32.92M
Insmed INSM:US $ 44.24M 75.64M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
Intra Cellular Therapies ITCI:US $ 722.2M 70.55M
Lexicon Pharmaceuticals LXRX:US $ 70.83M 21.87M
Moderna Inc MRNA:US 17.98B 910M
Omeros OMER:US $ -32702000 27.78M
Ptc Therapeutics PTCT:US $ -182.22M 91.64M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Sangamo Biosciences SGMO:US $ 318.28M 16.24M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Seattle Genetics SGEN:US $ 2932.81M 65.66M
Teva Pharmaceutical TEVA:IT 9.04B 307M
United Therapeutics UTHR:US $ 4318.4M 142.1M
Vertex Pharmaceuticals VRTX:US $ 11933.5M 1026.5M